<?xml version="1.0" encoding="UTF-8"?>
<p id="p0205">Actinomycetes are present in various environments and are active in the microbial communities. The secondary metabolites of these organisms are potential antiviral agents (
 <xref rid="t0030" ref-type="table">Table 6</xref> ). Xiamycin and its methyl ester of 
 <italic>Streptomyces</italic> sp. GT2002/1503 showed selective anti-HIV-1 activity (
 <xref rid="bb1625" ref-type="bibr">Xu et al., 2014</xref>). The compound (4
 <italic>S</italic>)-4-hydroxy-10-methyl-11-oxo-dodec-2-en-1,4-olide, identified from 
 <italic>Streptomyces</italic> sp. Smu03 possessed antiviral property over a broad range of Influenza A virus (
 <xref rid="bb0815" ref-type="bibr">Li et al., 2018</xref>). Antimycin A from 
 <italic>Streptomyces kaviengensis</italic> inhibited RNA virus families like 
 <italic>Togaviridae</italic>, 
 <italic>Picornaviridae</italic>, 
 <italic>Bunyaviridae</italic>, and western equine encephalitis virus. AhmpatininiBu from 
 <italic>Streptomyces</italic> sp. CPCC 202950 and 4862F from 
 <italic>Streptomyces albosporus</italic> I03A-04862 inhibited HIV-1 protease. Narasin from 
 <italic>Streptomyces aureofaciens</italic> prohibited post-entry stages of viral replication during Dengue virus infection (
 <xref rid="bb1470" ref-type="bibr">Teixeira et al., 2014</xref>). Other antivirals include daptomycin from 
 <italic>Streptomyces roseosporus</italic> (
 <xref rid="bb0595" ref-type="bibr">Jakubiec-Krzesniak et al., 2018</xref>), diffusomycin from 
 <italic>Streptomyces</italic> sp. KBFP-2025 (
 <xref rid="bb1550" ref-type="bibr">Vil et al., 2019</xref>), and Sinefungin from 
 <italic>Streptomyces griseolus</italic> and 
 <italic>Streptomyces incarnatus</italic> NRRL 8089 (
 <xref rid="bb0205" ref-type="bibr">Chen et al., 2017</xref>).
</p>
